A few years ago, the expert public was discussing the consequences of consolidating the EU countries' representation in the IMF's Executive Board. The main idea was that EU members should be split into two constituencies. - the first one with members of the eurozone and the other a members outside the eurozone. The subject of this paper is to analyse the voting power in the Executive Committee of the International Monetary Fund using the Penrose-Banzhaf Index (PBI) and the Koleman's Index (CI). The aim of the paper is to express the power of voting and the possibility of blocking certain decisions in relation to the position in the constituency. We will also take a look at the characteristics of the official missions of the IMF in order to determine the importance of the results and recommendations arising from the visit of the IMF team to the country.

Cilj rada je da se ispita korelacija između dostignutog nivoa tehnologije i inovacija i razvoja finansijskog tržišta, indeksa humanog razvoja i bruto domaćeg proizvoda po glavi stanovnika. Istraživačko pitanje glasi: „Da li su, i u kakvoj vezi, nivo tehnologije i inovacija sa indeksom razvijenosti tržišta, indeksom ljudskog razvoja i BDP-om po glavi stanovnika?” Cilj istraživanja je da utvrdimo da li ima osnova za verovanje da je „kopiranjem” određene zemlje po nivou digitalizacije i inovacija moguće dodatno razviti finansijsko tržište, uticati na nivo ljudskog razvoja ili na povećanje BDP-a po glavi stanovnika. Metode korištene u radu su regresiona analiza, odnosno prosta linearna regresija, te analiza i sinteza prethodnih istraživanja i teoretskih nalaza, da bi zaključci bili izvučeni metodom indukcije. Rad predstavlja doprinos autora ekonomskoj teoriji i praksi, te široj javnosti. Rezultati istraživanja još ukazuju i da bi bilo racionalno da finansijski posrednici u zemljama u razvoju razmotre izmjenu svojih poslovnih modela i mogućnosti za njihovo prilagođavanje ubrzanim tehnološkim promjenama.

Hypertension with high cardiovascular (CV) risk is characterized by significant increase of one of the risk factors, especially cholesterol above 8 mmol/l in, for instance, familial hypercholesterolemia, or blood pressure (BP) ≥180/110 mmHg (stage III hypertension), diabetes mellitus, hypertensive left ventricular hypertrophy (LVH), moderate chronic renal failure with eGFR of 30-59 mL/min/1.73 m2 and/or calculated 10-year SCORE of 5-10%. Case report: We presented in this paper a patient with hypertension and high risk in whom diastolic hypertension, left ventricular hypertrophy, metabolic syndrome and obesity were predominant in the beginning, while diabetes mellitus prevailed in the further disease course. We presented the diagnostic protocol, as well as the risk assessment according to the European and American guidelines, and a proper selection of non-medicamentous and medicamentous therapy. The patient was treated and observed for 20 years, and the therapy based on the official hypertension guidelines was able to prevent major cardiovascular events and to suspend the progression of target organ damage in hypertension. Conclusion: Proper risk assessment in hypertensive patients, presence of risk factors and target organ damage have a decisive role in the selection of adequate therapy in hypertension. Achievement of target BP values, control of risk factors and regression of target organ damage constitute the basis of good quality of life of hypertensive patients and prevention of major cardiovascular events.